{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:41:43Z","timestamp":1779154903797,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/1469-0691.12695","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T16:25:21Z","timestamp":1401380721000},"page":"O1098-O1105","source":"Crossref","is-referenced-by-count":41,"title":["Impact of source of infection and vancomycin AUC0\u201324\/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia"],"prefix":"10.1016","volume":"20","author":[{"given":"N.","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Chavada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12695_bib1","doi-asserted-by":"crossref","first-page":"654858","DOI":"10.1155\/2010\/654858","article-title":"Clinical and microbiological determinants of outcome in Staphylococcus aureus bacteraemia","volume":"2010","author":"Price","year":"2010","journal-title":"Int J Microbiol"},{"key":"10.1111\/1469-0691.12695_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/j.1326-5377.2009.tb02841.x","article-title":"Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand","volume":"191","author":"Turnidge","year":"2009","journal-title":"Med J Aust"},{"key":"10.1111\/1469-0691.12695_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12695_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/cit460","article-title":"Reply to Parra\u2010Ruiz","volume":"57","author":"van Hal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/1469-0691.12695_bib6","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin\u2010resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise\u2010Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/1469-0691.12695_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health\u2010system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/1469-0691.12695_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.05609-11","article-title":"Vancomycin auc24\/mic ratio in patients with complicated bacteremia and infective endocarditis due to methicillin\u2010resistant Staphylococcus aureus and its association with attributable mortality during hospitalization","volume":"56","author":"Brown","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.clinthera.2013.05.008","article-title":"A stewardship program's retrospective evaluation of vancomycin auc24\/mic and time to microbiological clearance in patients with methicillin\u2010resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"35","author":"Gawronski","year":"2013","journal-title":"Clin Ther"},{"key":"10.1111\/1469-0691.12695_bib11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.01485-12","article-title":"Vancomycin auc\/mic ratio and 30\u2010day mortality in patients with Staphylococcus aureus bacteremia","volume":"57","author":"Holmes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin\u2010resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib13","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High\u2010dose vancomycin therapy for methicillin\u2010resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/1469-0691.12695_bib14","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/518451","article-title":"Point: vancomycin is not obsolete for the treatment of infection caused by methicillin\u2010resistant Staphylococcus aureus","volume":"44","author":"Mohr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1592\/phco.31.5.441","article-title":"Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15\u201020 mg\/l suggested by the vancomycin consensus guidelines","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12695_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta\u2010analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta\u2010analysis of vancomycin\u2010induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/imj.12036","article-title":"Vancomycin therapeutics and monitoring: a contemporary approach","volume":"43","author":"Avent","year":"2013","journal-title":"Intern Med J"},{"key":"10.1111\/1469-0691.12695_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care"},{"key":"10.1111\/1469-0691.12695_bib20","series-title":"Performance standards for antimicrobial susceptibility testing: M100\u2010S16","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1111\/1469-0691.12695_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/AAC.32.6.848","article-title":"Vancomycin pharmacokinetics in patients with various degrees of renal function","volume":"32","author":"Rodvold","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib22","first-page":"1","article-title":"Rediction of creatinine clearance from serum creatinine","volume":"6","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/1469-0691.12695_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin\u2010resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib24","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin\u2010resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.47.4.1262-1266.2003","article-title":"Vancomycin treatment failure associated with heterogeneous vancomycin\u2010intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis","volume":"47","author":"Moore","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration\u2010time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12695_bib27","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/1469-0691.12695_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin trough concentrations adequate for optimal dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12695_bib29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/JCM.00448-13","article-title":"Evaluation of vancomycin susceptibility testing for methicillin\u2010resistant Staphylococcus aureus: comparison of Etest and three automated testing methods","volume":"51","author":"Rybak","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12695_bib30","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/jac\/dkr280","article-title":"Methicillin\u2010resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns","volume":"66","author":"van Hal","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12695_bib31","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.01674-10","article-title":"Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding","volume":"55","author":"Butterfield","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15600659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T09:31:04Z","timestamp":1597915864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15600659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1198743X15600659"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12695","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}